Statute of Limitations
Delaware imposes a 2-year statute of limitations for personal injury claims (10 Del. C. § 8119). The discovery rule applies. Delaware applies the Daubert standard under D.R.E. 702, but Judge Medinilla in the Delaware Superior Court Zantac coordination has allowed plaintiffs' causation experts to proceed, distinguishing Delaware from the federal MDL's Daubert exclusion. Delaware is the primary active national venue for Zantac litigation as of 2025-2026.
2 years from date of cancer diagnosis discovery (Delaware Superior Court — most favorable active venue)
Exposure in Delaware
Source: Delaware Superior Court dockets 2025
Source: Delaware Superior Court case management orders
Clinics & Specialists in Delaware
Helen F. Graham Cancer Center & Research Institute (ChristianaCare)
Tunnel Cancer Center (Beebe Healthcare)
Your Legal Team
Robert Callahan
Senior Partner
Wilmington, DE
Robert Callahan has spent 20 years representing plaintiffs in pharmaceutical mass tort litigation, with a particular focus on Delaware Superior Court proceedings. His biochemistry background gives him a unique advantage in pharmaceutical causation cases — he understands the science underlying ranitidine NDMA formation and can explain it compellingly to juries and in expert witness proceedings. Robert has been actively involved in Delaware's consolidated Zantac litigation since 2023 and has worked with leading toxicology and oncology experts to develop state-court-specific causation theories that address the methodological criticisms raised in the federal MDL Daubert proceedings. He has recovered over $85 million for pharmaceutical injury clients in his career.
Education
- J.D., University of Pennsylvania Carey Law School (2006)
- B.S., Biochemistry, University of Delaware (2003)